Differential parsing of EGFR endocytic flux among parallel internalization pathways in lung cancer cells with EGFR-activating mutations

Integrative Biology (United Kingdom)

Volumn 6, Issue 3, 2014, Pages 312-323

  Walsh, Alice M ^a   Lazzara, Matthew J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; CANCER CELL; ENDOCYTOSIS; INTERNALIZATION; LUNG CANCER; LUNG NON SMALL CELL CANCER; PHOSPHORYLATION AND DEPHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CLATHRIN; ENDOCYTOSIS; GENE KNOCKDOWN TECHNIQUES; GENES, ERBB-1; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; MUTATION; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-CBL; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84896809368     PISSN: 17579694     EISSN: 17579708     Source Type: Journal    
DOI: 10.1039/c3ib40176f     Document Type: Article

References (40)

1. A. Sorkin M. von Zastrow Endocytosis and signalling: intertwining molecular networks Nat. Rev. Mol. Cell Biol. 2009 10 609 622
2. J. V. Abella M. Park Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases Am. J. Physiol.: Endocrinol. Metab. 2009 296 E973 E984
3. Y. Mosesson G. B. Mills Y. Yarden Derailed endocytosis: an emerging feature of cancer Nat. Rev. Cancer 2008 8 835 850
4. A. Sorkin L. K. Goh Endocytosis and intracellular trafficking of ErbBs Exp. Cell Res. 2009 315 683 696
5. M. H. Schmidt I. Dikic The Cbl interactome and its functions Nat. Rev. Mol. Cell Biol. 2005 6 907 918 (Pubitemid 41778710)
6. P. Soubeyran K. Kowanetz I. Szymkiewicz W. Y. Langdon I. Dikic Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors Nature 2002 416 183 187 (Pubitemid 34246476)
7. S. Anastasi L. Fiorentino M. Fiorini R. Fraioli G. Sala L. Castellani S. Alema M. Alimandi O. Segatto Feedback inhibition by RALT controls signal output by the ErbB network Oncogene 2003 22 4221 4234 (Pubitemid 36876243)
8. Y. Frosi S. Anastasi C. Ballaro G. Varsano L. Castellani E. Maspero S. Polo S. Alema O. Segatto A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation J. Cell Biol. 2010 189 557 571
9. H. Ying H. Zheng K. Scott R. Wiedemeyer H. Yan C. Lim J. Huang S. Dhakal E. Ivanova Y. Xiao H. Zhang J. Hu J. M. Stommel M. A. Lee A. J. Chen J. H. Paik O. Segatto C. Brennan L. A. Elferink Y. A. Wang L. Chin R. A. DePinho Mig-6 controls EGFR trafficking and suppresses gliomagenesis Proc. Natl. Acad. Sci. U. S. A. 2010 107 6912 6917
10. X. Zhang K. A. Pickin R. Bose N. Jura P. A. Cole J. Kuriyan Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface Nature 2007 450 741 744 (Pubitemid 350207680)
11. K. Haglund M. H. Schmidt E. S. Wong G. R. Guy I. Dikic Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation EMBO Rep. 2005 6 635 641 (Pubitemid 41122431)
12. C. Rubin V. Litvak H. Medvedovsky Y. Zwang S. Lev Y. Yarden Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops Curr. Biol. 2003 13 297 307 (Pubitemid 36230020)
13. E. S. Wong C. W. Fong J. Lim P. Yusoff B. C. Low W. Y. Langdon G. R. Guy Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling EMBO J. 2002 21 4796 4808
14. S. Sigismund E. Argenzio D. Tosoni E. Cavallaro S. Polo P. P. Di Fiore Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation Dev. Cell 2008 15 209 219
15. B. S. Hendriks G. J. Griffiths R. Benson D. Kenyon M. Lazzara J. Swinton S. Beck M. Hickinson J. M. Beusmans D. Lauffenburger D. de Graaf Decreased internalisation of erbB1 mutants in lung cancer is linked with a mechanism conferring sensitivity to gefitinib Syst. Biol. 2006 153 457 466 (Pubitemid 44712261)
16. B. Schoeberl E. A. Pace J. B. Fitzgerald B. D. Harms L. Xu L. Nie B. Linggi A. Kalra V. Paragas R. Bukhalid V. Grantcharova N. Kohli K. A. West M. Leszczyniecka M. J. Feldhaus A. J. Kudla U. B. Nielsen Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis Sci. Signaling 2009 2 ra31
17. H. S. Wiley D. D. Cunningham A steady state model for analyzing the cellular binding, internalization and degradation of polypeptide ligands Cell 1981 25 433 440 (Pubitemid 11046834)
18. M. Gex-Fabry C. DeLisi Receptor-mediated endocytosis: a model and its implications for experimental analysis Am. J. Physiol. 1984 247 R768 R779
19. C. Starbuck D. A. Lauffenburger Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses Biotechnol. Prog. 1992 8 132 143
20. C. S. Monast C. M. Furcht M. J. Lazzara Computational analysis of the regulation of EGFR by protein tyrosine phosphatases Biophys. J. 2012 102 2012 2021
21. A. M. Walsh M. J. Lazzara Regulation of EGFR trafficking and cell signaling by Sprouty2 and MIG6 in lung cancer cells J. Cell Sci. 2013 126 4339 4348
22. M. J. Lazzara K. Lane R. Chan P. J. Jasper M. B. Yaffe P. K. Sorger T. Jacks B. G. Neel D. A. Lauffenburger Impaired SHP2-mediated extracellular signal-regulated kinase activation contributes to gefitinib sensitivity of lung cancer cells with epidermal growth factor receptor-activating mutations Cancer Res. 2010 70 3843 3850
23. S. Yang S. Qu M. Perez-Tores A. Sawai N. Rosen D. B. Solit C. L. Arteaga Association with HSP90 inhibits Cbl-mediated down-regulation of mutant epidermal growth factor receptors Cancer Res. 2006 66 6990 6997 (Pubitemid 44197674)
24. D. Padron M. Sato J. W. Shay A. F. Gazdar J. D. Minna M. G. Roth Epidermal growth factor receptors with tyrosine kinase domain mutations exhibit reduced Cbl association, poor ubiquitylation, and down-regulation but are efficiently internalized Cancer Res. 2007 67 7695 7702 (Pubitemid 47281362)
25. J. Amann S. Kalyankrishna P. P. Massion J. E. Ohm L. Girard H. Shigematsu M. Peyton D. Juroske Y. Huang J. Stuart Salmon Y. H. Kim J. R. Pollack K. Yanagisawa A. Gazdar J. D. Minna J. M. Kurie D. P. Carbone Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer Cancer Res. 2005 65 226 235 (Pubitemid 40070814)
26. T. J. Lynch D. W. Bell R. Sordella S. Gurubhagavatula R. A. Okimoto B. W. Brannigan P. L. Harris S. M. Haserlat J. G. Supko F. G. Haluska D. N. Louis D. C. Christiani J. Settleman D. A. Haber Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N. Engl. J. Med. 2004 350 2129 2139 (Pubitemid 38637993)
27. J. G. Paez P. A. Janne J. C. Lee S. Tracy H. Greulich S. Gabriel P. Herman F. J. Kaye N. Lindeman T. J. Boggon K. Naoki H. Sasaki Y. Fujii M. J. Eck W. R. Sellers B. E. Johnson M. Meyerson EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 2004 304 1497 1500 (Pubitemid 38720929)
28. K. A. Lund L. K. Opresko C. Starbuck B. J. Walsh H. S. Wiley Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization J. Biol. Chem. 1990 265 15713 15723
29. J. M. Mason D. J. Morrison B. Bassit M. Dimri H. Band J. D. Licht I. Gross Tyrosine phosphorylation of Sprouty proteins regulates their ability to inhibit growth factor signaling: a dual feedback loop Mol. Biol. Cell 2004 15 2176 2188 (Pubitemid 38580637)
30. B. N. Kholodenko O. V. Demin G. Moehren J. B. Hoek Quantification of short term signaling by the epidermal growth factor receptor J. Biol. Chem. 1999 274 30169 30181
31. S. H. Northrup H. P. Erickson Kinetics of protein-protein association explained by Brownian dynamics computer simulation Proc. Natl. Acad. Sci. U. S. A. 1992 89 3338 3342
32. C. M. Furcht A. R. Muñoz Rojas D. Nihalani M. J. Lazzara Diminished functional role and altered localization of SHP2 in non-small cell lung cancer cells with EGFR-activating mutations Oncogene 2013 32 2346 2355
33. H. Greulich T. H. Chen W. Feng P. A. Janne J. V. Alvarez M. Zappaterra S. E. Bulmer D. A. Frank W. C. Hahn W. R. Sellers M. Meyerson Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants PLoS Med. 2005 2 1167 1176 (Pubitemid 41735785)
34. A. Guo J. Villen J. Kornhauser K. A. Lee M. P. Stokes K. Rikova A. Possemato J. Nardone G. Innocenti R. Wetzel Y. Wang J. MacNeill J. Mitchell S. P. Gygi J. Rush R. D. Polakiewicz M. J. Comb Signaling networks assembled by oncogenic EGFR and c-Met Proc. Natl. Acad. Sci. U. S. A. 2008 105 692 697 (Pubitemid 351171770)
35. D. Patel A. Lahiji S. Patel M. Franklin X. Jimenez D. J. Hicklin X. Kang Monoclonal antibody cetuximab binds to and down-regulates constitutively activated epidermal growth factor receptor vIII on the cell surface Anticancer Res. 2007 27 3355 3366 (Pubitemid 47607562)
36. A. R. French G. P. Sudlow H. S. Wiley D. A. Lauffenburger Postendocytic trafficking of epidermal growth factor-receptor complexes is mediated through saturable and specific endosomal interactions J. Biol. Chem. 1994 269 15749 15755 (Pubitemid 24202170)
37. B. S. Hendriks H. S. Wiley D. Lauffenburger HER2-mediated effects on EGFR endosomal sorting: analysis of biophysical mechanisms Biophys. J. 2003 85 2732 2745 (Pubitemid 37210819)
38. Z. Wang P. A. Longo M. K. Tarrant K. Kim S. Head D. J. Leahy P. A. Cole Mechanistic insights into the activation of oncogenic forms of EGF receptor Nat. Struct. Mol. Biol. 2011 18 1388 1393
39. X. Zhang J. Gureasko K. Shen P. A. Cole J. Kuriyan An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor Cell 2006 125 1137 1149 (Pubitemid 43866200)
40. N. Liu M. Matsumoto K. Kitagawa Y. Kotake S. Suzuki S. Shirasawa K. I. Nakayama M. Nakanishi H. Niida M. Kitagawa Chk1 phosphorylates the tumour suppressor Mig-6, regulating the activation of EGF signalling EMBO J. 2012 31 2365 2377